Invesco Nasdaq Biotechnology ETF (IBBQ)

Assets	$125.15M
Expense Ratio	0.19%
PE Ratio	25.55
Forward PE	18.06
Shares Out	3.57M
Dividend	$0.39 (1.07%)
Ex-Dividend Date	Sep 21, 2026
Payout Frequency	Quarterly
Payout Ratio	27.42%

Volume	59,450
Open	36.81
Previous Close	36.85
Day's Range	36.19 - 36.81
52-Week Low	26.57
52-Week High	37.01
Beta	0.63
Holdings	255
Inception Date	Jun 11, 2021

About IBBQ

Fund Home Page

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is issued by Invesco.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: Nasdaq
• Ticker Symbol: IBBQ
• ETF Provider: Invesco
• Index Tracked: NASDAQ / Biotechnology

Top 10 Holdings

48.32% of assets

Name	Symbol	Weight
Gilead Sciences, Inc.	GILD	8.86%
Amgen Inc.	AMGN	8.29%
Vertex Pharmaceuticals Incorporated	VRTX	7.74%
Moderna, Inc.	MRNA	6.72%
Regeneron Pharmaceuticals, Inc.	REGN	5.82%
Revolution Medicines, Inc.	RVMD	2.69%
Biogen Inc.	BIIB	2.36%
Illumina, Inc.	ILMN	2.09%
Royalty Pharma plc	RPRX	1.92%
Roivant Sciences Ltd.	ROIV	1.84%

Dividend History

Ex-Dividend	Amount	Pay Date
Sep 21, 2026	$0.23037	Sep 25, 2026
Jun 22, 2026	$0.03422	Jun 26, 2026
Mar 23, 2026	$0.03609	Mar 27, 2026
Dec 22, 2025	$0.0906	Dec 26, 2025
Sep 22, 2025	$0.09576	Sep 26, 2025
Jun 23, 2025	$0.0287	Jun 27, 2025

Performance

IBBQ had a total return of 39.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.92%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Nov 10, 2026

Data Sources Report a data error